Funded Tech Companies
Promentis Pharmaceuticals
Promentis Pharmaceuticals, based in Milwaukee, received equity investments from OrbiMed, Aisling Capital and F-Prime Capital.
Company Overview
Company Name
Promentis Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
826 N. Plankinton Ave. 400
Milwaukee, WI 53203
USA
Milwaukee, WI 53203
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Promentis Pharmaceuticals, Inc. is a pharmaceutical company developing novel compounds for the treatment of schizophrenia and other central nervous system disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Klaus Veitinger
President
Daniel Lawton
VP - Finance
Stacy Holland
VP - R & D
Chad Beyer
VP - R & D
Michael Neary
Company Investors
- OrbiMed (Klaus Veitinger)
- Aisling Capital (Stacey Seltzer)
- F-Prime Capital (Thomas Beck)
- Golden Angels Investors
- Black Horse Investments (Patrick Schwarz-Schuette)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs